Insider · CIK 0001370087
James O Armitage
Files at CRDF (Cardiff Oncology, Inc.). First filing -, latest -.
In brief
James O Armitage files SEC Form 4 as director at CRDF (Cardiff Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James O Armitage has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +40,565 | $0.00 | $0 | 228,104 | Jun 15, 2026 |
| Jun 26, 2025 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +40,565 | $0.00 | $0 | 187,539 | Jun 27, 2025 |
Questions about James O Armitage
Answered from the filings on this page, as of the latest one.
Is James O Armitage buying or selling?
James O Armitage has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James O Armitage's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James O Armitage has 0.
Where does James O Armitage file Form 4?
James O Armitage has filed Form 4 at CRDF (Cardiff Oncology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.